Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 5,283,685 | 10,377,000 | 9,816,665 | 9,616,291 | 9,040,850 |
| Cost of Goods | 2,359,164 | 3,838,000 | 3,973,250 | 3,870,472 | 3,858,983 |
| Gross Profit | 2,924,521 | 6,539,000 | 5,843,415 | 5,745,819 | 5,181,867 |
| Operating Expenses | 2,415,500 | 4,457,000 | 5,248,787 | 3,972,838 | 3,881,701 |
| Operating Income | 509,185 | 2,082,000 | 594,878 | 1,773,453 | 1,301,149 |
| Interest Expense | 82,080 | 102,000 | 124,339 | 134,129 | 145,587 |
| Other Income | 36,271 | -26,000 | 31,056 | 35,232 | -86,776 |
| Pre-tax Income | 463,376 | 1,954,000 | 501,595 | 1,674,556 | 1,068,786 |
| Income Tax | 112,161 | 335,000 | 198,414 | -268,226 | 204,968 |
| Net Income Continuous | 351,215 | 1,619,000 | 303,181 | 1,942,782 | 863,818 |
| Net Income Discontinuous | 890,909 | N/A | N/A | N/A | N/A |
| Net Income | $1,242,124 | $1,619,000 | $303,181 | $1,942,782 | $863,818 |
| EPS Basic Total Ops | 0.79 | 1.04 | 0.19 | 1.24 | 0.56 |
| EPS Basic Continuous Ops | 0.22 | -1.28 | 0.19 | 1.25 | 0.56 |
| EPS Basic Discontinuous Ops | 0.57 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.78 | 1.02 | 0.19 | 1.23 | 0.55 |
| EPS Diluted Continuous Ops | 0.22 | 1.03 | 0.19 | 1.24 | 0.55 |
| EPS Diluted Discontinuous Ops | 0.56 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,252,452 | $2,730,535 | $1,433,264 | $2,584,865 | $2,046,815 |